Skip to menu Skip to content Skip to footer

Novel Hybrid Inorganic Nanoparticles for Effective siRNA Delivery to Neurons (2008-2012)

Abstract

This project aims to develop a novel class of hybrid inorganic nanoparticles for effective delivery of therapeutic siRNAs, either locally or systemically, into the mouse central nervous system to slow the progression of Huntington's disease, one typical neurodegenerative disease. To this end, a more efficient and reliable delivery system will be devised by combining advantages of both layered double hydroxide and silica materials, with suitable surface functionalisation. Such a system will promote passage across the blood brain barrier and improve efficient neuronal uptake of novel drugs (e.g. siRNAs) leading to the effective treatment of genetic and other neuronal diseases.

Experts

Professor Helen Cooper

Affiliate of Centre for RNA in Neuroscience
Centre for RNA in Neuroscience
Faculty of Health, Medicine and Behavioural Sciences
Deputy Director (Research)
Queensland Brain Institute
Faculty of Health, Medicine and Behavioural Sciences
Helen Cooper